Smart dialysis machine aims to stop dangerous blood pressure drops

NCT ID NCT06376968

Recruiting now Disease control Sponsor: B.Braun Avitum AG Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a new feature on a dialysis machine that tries to predict and prevent sudden drops in blood pressure during treatment. About 56 adults on long-term dialysis who often have low blood pressure will be randomly assigned to use the feature or not, then switch. The goal is to see if the feature helps patients reach their target fluid removal safely.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: DialogiQ dialysis machine with BioLogic Fusion feedback system
What this could lead to: If it works, this could make dialysis safer and more comfortable for patients prone to low blood pressure.
What could go wrong: This is a small, early-stage study with only 56 participants, so results may not apply to everyone. The feature may not prevent all hypotensive episodes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END-STAGE RENAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RENAL DIALYSIS

Contacts and locations

Locations

Policlinico S. Orsola - Malpighi - UOC Nefrologia, Dialisi e Ipertensione
RECRUITING

Bologna, Emilia-Romagna, 40138, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.